This Popular Brain Supplement Was Linked to Shorter Lifespans in Men

Why It Matters

If confirmed, the findings could reshape dietary supplement recommendations and spark new research into amino‑acid metabolism as a modifiable factor in male longevity.

Key Takeaways

• Tyrosine levels correlated with ~1‑year shorter lifespan in men
• Phenylalanine showed no significant impact on longevity for either sex
• Mendelian randomization supports potential causal link, not just correlation
• Study did not assess supplement use; implications for products remain uncertain

Pulse Analysis

The market for brain‑health supplements has surged, with tyrosine often highlighted for its role in neurotransmitter synthesis and cognitive focus. Consumers routinely add it to powders, capsules, or fortified drinks, believing it boosts mental performance during stress. Yet the nutrient’s broader physiological effects remain under‑explored, especially its interaction with metabolic pathways that influence aging. By situating the new findings within this booming supplement landscape, readers gain perspective on why a seemingly benign amino acid warrants closer scrutiny beyond short‑term performance gains.

The research leveraged the UK Biobank, analyzing genetic and clinical data from more than 270,000 adults. Using both observational correlations and Mendelian randomization—a technique that treats genetic variants as natural experiments—the team isolated tyrosine as the only amino acid consistently tied to higher mortality in men. The effect translated to an estimated one‑year reduction in lifespan, while women showed no statistically meaningful relationship. Proposed mechanisms include insulin resistance, altered stress‑hormone signaling, and sex‑specific hormone pathways, though causality remains speculative pending mechanistic studies.

For the nutraceutical industry and health‑conscious consumers, the study signals a need for caution. While the analysis did not examine supplemental tyrosine directly, the link between elevated blood levels and reduced male longevity suggests that dosage, baseline diet, and individual metabolism could matter. Companies may consider reformulating products or providing clearer labeling about potential risks, especially for male users. Meanwhile, clinicians and researchers are likely to pursue follow‑up trials to test whether dietary adjustments or targeted interventions can safely modulate tyrosine levels and improve aging outcomes. Until such evidence emerges, a balanced protein intake and personalized supplement strategies remain prudent.